PER 1.41% 7.0¢ percheron therapeutics limited

Ann: ANP Updates on US Regulatory Plans for ATL1102 in DMD, page-121

  1. 38 Posts.
    lightbulb Created with Sketch. 3
    Short term price weakness is expected due to the additional uncertainty. I don't think the market is mis-pricing this. The fundamental has not changed in the long term.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.